Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Teva
Covington
Harvard Business School
Julphar
Federal Trade Commission
QuintilesIMS
Johnson and Johnson
AstraZeneca
Express Scripts
Mallinckrodt

Generated: August 20, 2017

DrugPatentWatch Database Preview

VALGANCICLOVIR HYDROCHLORIDE Drug Profile

« Back to Dashboard

What is the patent landscape for Valganciclovir Hydrochloride, and when can generic versions of Valganciclovir Hydrochloride launch?

Valganciclovir Hydrochloride is a drug marketed by Dr Reddys Labs Ltd, Actavis Labs Fl Inc, Aurobindo Pharma Ltd, Hetero Labs Ltd V, and Endo Pharms Inc. and is included in five NDAs.

The generic ingredient in VALGANCICLOVIR HYDROCHLORIDE is valganciclovir hydrochloride. There are fifteen drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the valganciclovir hydrochloride profile page.

Summary for Tradename: VALGANCICLOVIR HYDROCHLORIDE

Patents:0
Applicants:5
NDAs:5
Suppliers / Packagers: see list9
Bulk Api Vendors: see list34
Clinical Trials: see list2,328
Patent Applications: see list123
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:VALGANCICLOVIR HYDROCHLORIDE at DailyMed

Pharmacology for Tradename: VALGANCICLOVIR HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Dr Reddys Labs Ltd
VALGANCICLOVIR HYDROCHLORIDE
valganciclovir hydrochloride
TABLET;ORAL203511-001Nov 4, 2014ABRXNoNo► Subscribe► Subscribe► Subscribe
Hetero Labs Ltd V
VALGANCICLOVIR HYDROCHLORIDE
valganciclovir hydrochloride
TABLET;ORAL205166-001Mar 18, 2016ABRXNoNo► Subscribe► Subscribe► Subscribe
Actavis Labs Fl Inc
VALGANCICLOVIR HYDROCHLORIDE
valganciclovir hydrochloride
FOR SOLUTION;ORAL205220-001Jul 18, 2016ABRXNoNo► Subscribe► Subscribe► Subscribe
Aurobindo Pharma Ltd
VALGANCICLOVIR HYDROCHLORIDE
valganciclovir hydrochloride
TABLET;ORAL204750-001Mar 31, 2016ABRXNoNo► Subscribe► Subscribe► Subscribe
Endo Pharms Inc
VALGANCICLOVIR HYDROCHLORIDE
valganciclovir hydrochloride
TABLET;ORAL200790-001Nov 4, 2014ABRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Moodys
Cerilliant
Deloitte
Colorcon
Argus Health
Harvard Business School
Daiichi Sankyo
AstraZeneca
Johnson and Johnson
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot